Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001017386-24-000024
Filing Date
2024-02-21
Accepted
2024-02-21 14:58:17
Documents
32
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT atpt_2023dec31-10q.htm   iXBRL 10-Q 296019
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) OF T atpt_ex31z1.htm EX-31.1 7624
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) OF T atpt_ex31z2.htm EX-31.2 7625
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1 atpt_ex32z1.htm EX-32.1 4042
5 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1 atpt_ex32z2.htm EX-32.2 4254
  Complete submission text file 0001017386-24-000024.txt   1303666

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atpt-20231231.xsd EX-101.SCH 8447
7 XBRL CALCULATION FILE atpt-20231231_cal.xml EX-101.CAL 15808
8 XBRL DEFINITION FILE atpt-20231231_def.xml EX-101.DEF 11660
9 XBRL LABEL FILE atpt-20231231_lab.xml EX-101.LAB 98427
10 XBRL PRESENTATION FILE atpt-20231231_pre.xml EX-101.PRE 69362
33 EXTRACTED XBRL INSTANCE DOCUMENT atpt_2023dec31-10q_htm.xml XML 90865
Mailing Address 7325 OSWEGO ROAD LIVERPOOL NY 13090
Business Address 7325 OSWEGO ROAD LIVERPOOL NY 13090 3154517515
PETRO USA, INC. (Filer) CIK: 0000745543 (see all company filings)

EIN.: 320252180 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12895 | Film No.: 24658880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)